| Why carry out this study? |
| Different treatment regimens exist for neuromyelitis optica spectrum disorder (NMOSD) and MOG-associated-antibody-diseases (MOGAD). |
| B-cell population monitoring is crucial for a personalized treatment approach. |
| CD27-positive B-cell monitoring could be more effective than B-cell monitoring. |
| What was learned from the study? |
| CD27-positive B-cell monitoring is safe and effective. |
| Lower infusion number could reduce treatment burden and risk of infectious events. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.